查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1977777

全球糖尿病視網膜病變市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Diabetic Retinopathy Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 113 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計糖尿病視網膜病變市場將從 2025 年的 62.2 億美元成長到 2034 年的 201.9 億美元，2026 年至 2034 年的複合年成長率為 13.97%。

由於全球糖尿病負擔日益加重，糖尿病視網膜病變市場正顯著擴張。糖尿病患者人數的增加也提高了視力併發症的風險，從而推動了對有效診斷和治療方案的需求。早期篩檢計畫和影像技術的進步提高了檢測率，也促進了市場成長。

關鍵促進因素包括抗血管內皮生長因子（VEGF）療法、雷射治療和外科手術的進步。人們對定期眼科檢查的意識提升，以及政府為促進糖尿病管理而採取的舉措，進一步推動了市場擴張。此外，人工智慧（AI）在視網膜成像中的應用，提高了診斷的準確性和效率。

展望未來，生物製藥療法和緩釋治療方案的持續創新可望惠及市場。遠距眼科服務和數位健康平台有望擴大眼科醫療服務的覆蓋範圍，尤其是在農村地區。隨著醫療系統日益重視預防糖尿病相關併發症，預計未來幾年糖尿病視網膜病變治療的需求將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球糖尿病視網膜病變市場：依類型分類

  • 市場分析、洞察與預測
  • 增殖性糖尿病視網膜病變
  • 糖尿病黃斑部水腫（DME）

第5章 全球糖尿病視網膜病變市場：依治療類型分類

  • 市場分析、洞察與預測
  • 抗 VEGF 藥物
  • 類固醇植入
  • 雷射手術
  • 玻璃體切除手術

第6章 全球糖尿病視網膜病變市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Alimera Science
    • AbbVie
    • Ampio Pharmaceuticals
    • Bayer
    • Kowa
    • Novartis
    • Pfizer
    • Regeneron Pharmaceuticals
    • F-Hoffmann-La Roche
    • Valeant Pharmaceuticals（Bausch Health Companies）
簡介目錄
Product Code: VMR112113274

The Diabetic Retinopathy Market size is expected to reach USD 20.19 Billion in 2034 from USD 6.22 Billion (2025) growing at a CAGR of 13.97% during 2026-2034.

The global diabetic retinopathy market is expanding significantly due to the rising global burden of diabetes. As the number of diabetic patients increases, the risk of vision-related complications is also growing, driving demand for effective diagnostic and treatment solutions. Early screening programs and improved imaging technologies have enhanced detection rates, supporting market growth.

Major drivers include advancements in anti-VEGF therapies, laser treatments, and surgical interventions. Increasing awareness about regular eye examinations and government initiatives promoting diabetes management are further strengthening market expansion. The integration of artificial intelligence in retinal imaging is also improving diagnostic accuracy and efficiency.

Looking forward, the market is expected to benefit from continued innovation in biologic therapies and long-acting treatment options. Teleophthalmology services and digital health platforms may expand access to eye care, particularly in rural areas. As healthcare systems focus on preventing diabetes-related complications, the demand for diabetic retinopathy treatments is projected to grow steadily in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Proliferative Diabetic Retinopathy
  • Diabetic Macular Edema (DME)

By Treatment Type

  • Anti VEGF Drug
  • Steroid Implants
  • Laser Surgeries
  • Vitrectomy

COMPANIES PROFILED

  • Alimera Science, AbbVie, Ampio Pharmaceuticals, Bayer, Kowa, Novartis, Pfizer, Regeneron Pharmaceuticals, FHoffmannLa Roche, Valeant Pharmaceuticals Bausch Health Companies
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIABETIC RETINOPATHY MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Proliferative Diabetic Retinopathy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Diabetic Macular Edema (DME) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIABETIC RETINOPATHY MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Treatment Type
  • 5.2. Anti VEGF Drug Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Steroid Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Laser Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Vitrectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIABETIC RETINOPATHY MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By Treatment Type
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By Treatment Type
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By Treatment Type
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By Treatment Type
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By Treatment Type
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL DIABETIC RETINOPATHY INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Alimera Science
    • 8.2.2 AbbVie
    • 8.2.3 Ampio Pharmaceuticals
    • 8.2.4 Bayer
    • 8.2.5 Kowa
    • 8.2.6 Novartis
    • 8.2.7 Pfizer
    • 8.2.8 Regeneron Pharmaceuticals
    • 8.2.9 F-Hoffmann-La Roche
    • 8.2.10 Valeant Pharmaceuticals (Bausch Health Companies)